Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > SentiMag® Now Available in Australia and New Zealand

Abstract:
Endomagnetics is pleased to announce it has reached an agreement with Aurora BioScience as its exclusive distributor for Australia and New Zealand. This appointment significantly extends the availability of the company's SentiMag® and Sienna+® tracer system. Breast cancer patients in the region will now have access to new technology that optimally locates lymph nodes as part of the cancer staging procedure in Sentinel Lymph Node Biopsy (SLNB).

SentiMag® Now Available in Australia and New Zealand

Cambridge, UK | Posted on July 21st, 2014

Current standard-of-care for SLNB requires a radioactive isotope injection, which has limited availability in Australia and New Zealand. The SentiMag system increases the availability of the standard-of-care and also improves workflow, putting the surgeon in control of tracer injection. The system has been used in 10 clinical studies and trials with over 1,500 patients across 12 European countries since 2012. The first two trials have published recently, and demonstrated clinical equivalence to the standard-of-care.

Aurora Bioscience is exclusively responsible for the sales, marketing and distribution of the SentiMag® system in the Australian and New Zealand markets. Aurora is a leading specialist distributor of high technology medical devices across fields including oncology, blood technology, respiratory medicine and neurology. It provides a service to metropolitan and regional areas across Australia and New Zealand and around the Pacific Islands.

Mathew Stephens, Director of Sales and Business Development at Endomagnetics said: "We are delighted to be working with the team at Aurora as this appointment significantly strengthens our distribution in this key geographical market. The interest from Australian and New Zealand surgeons has been huge and we are looking forward to developments in the coming months."

For Aurora BioScience, Darren Banks, Managing Director said: "The Endomagnetics technology is a perfect fit with our advanced, innovative range of medical devices, and the technology will significantly improve patient experience by extending availability of the SLNB technique".

####

About Endomagnetics
Endomagnetics Ltd was founded to solve cancer staging and healthcare challenges through the application of advanced magnetic sensing technology and nanotechnology. Endomagnetics is developing a portfolio of medical device products based on a patented ability to detect magnetic materials in the human body with exceptional sensitivity. The technology was originally developed at University College London and the University of Houston.

The company’s first product, the SentiMag®, is an ultrasensitive hand-held probe for tracking injected Sienna+® nanoscale magnetic materials in the human body. Cambridge, UK-based Endomagnetics is in the process of delivering its technology to global markets.

About Aurora BioScience

Located in Sydney Australia, Aurora BioScience Pty Ltd is committed to providing advanced, high quality medical devices and healthcare products to assist medical professionals within Australia, New Zealand and the Pacific Islands healthcare markets, to contribute to the enhancement of patient’s quality of life. Areas of interest include cancer therapies, neurology, pulmonology, and haematology and blood products.

For more information, please visit www.aurorabioscience.com.au

For more information, please click here

Contacts:
Editorial contact:
Terry Nicklin
KeynotePR Ltd
Tel: +44 (0)7923 540695


Company contact:
Dr Eric Mayes, CEO
Endomagnetics Ltd
Tel: +44 (0)1223 652540

Copyright © Endomagnetics

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Basque researchers turn light upside down February 23rd, 2018

Stiffness matters February 23rd, 2018

Imaging individual flexible DNA 'building blocks' in 3-D: Berkeley Lab researchers generate first images of 129 DNA structures February 22nd, 2018

'Memtransistor' brings world closer to brain-like computing: Combined memristor and transistor can process information and store memory with one device February 22nd, 2018

Imaging

Histology in 3-D: New staining method enables Nano-CT imaging of tissue samples February 22nd, 2018

Imaging individual flexible DNA 'building blocks' in 3-D: Berkeley Lab researchers generate first images of 129 DNA structures February 22nd, 2018

Nanomedicine

Stiffness matters February 23rd, 2018

Histology in 3-D: New staining method enables Nano-CT imaging of tissue samples February 22nd, 2018

Imaging individual flexible DNA 'building blocks' in 3-D: Berkeley Lab researchers generate first images of 129 DNA structures February 22nd, 2018

Arrowhead Receives Regulatory Clearance to Begin Phase 1 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease February 22nd, 2018

Announcements

Basque researchers turn light upside down February 23rd, 2018

Stiffness matters February 23rd, 2018

Histology in 3-D: New staining method enables Nano-CT imaging of tissue samples February 22nd, 2018

Developing reliable quantum computers February 22nd, 2018

Alliances/Trade associations/Partnerships/Distributorships

New era in high field superconducting magnets – opening new frontiers in science, nanotechnology and materials discovery January 9th, 2018

Leti Field Trials Demonstrate New Multicarrier Waveform for Rural, Maritime Broadband Radio: Field Trial in Orkney Islands Used New Filtered Multicarrier Waveform at 700MHz Band with Flexible Bandwidth Usage (Fragmented and Continuous Spectrum) December 18th, 2017

A new product to help combat mouldy walls, thanks to technology developed at the ICN2 December 14th, 2017

JPK Instruments announce partnership with Swiss company, Cytosurge AG. The partnership makes Cytosurge’s FluidFM® technology available on the JPK NanoWizard® AFM platform December 8th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project